| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-10 |
| filingDate |
1983-09-22^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-07-16^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caba8df4f69a7a8d35652b49b304c52e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb78ed2e05baa91721eacef75d9b167 |
| publicationDate |
1985-07-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4529731-A |
| titleOfInvention |
Thiadiazolediamine derivative with histamine H-2 receptor inhibiting properties |
| abstract |
N-[2-(dimethylamino)ethyl]-N'-[3-[3-[(1-piperidinyl)methyl]phenoxy]-pr opyl]-1,2,5-thiadiazole-3,4-diamine, 1-oxide is a long acting histamine H-2 receptor antagonist. The compound inhibits gastric acid secretion, and prevents and alleviates ulcers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022034121-A1 |
| priorityDate |
1983-09-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |